{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:22:00Z","timestamp":1791069720631,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,2,19]],"date-time":"2011-02-19T00:00:00Z","timestamp":1298073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00210-011-0609-y","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T04:00:30Z","timestamp":1298001630000},"page":"393-402","source":"Crossref","is-referenced-by-count":7,"title":["Verapamil exerts biphasic modulation on phenobarbital transport across the blood\u2013brain barrier: evidence from an in vivo and in vitro study"],"prefix":"10.1007","volume":"383","author":[{"given":"Dan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Ji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,19]]},"reference":[{"key":"609_CR1","doi-asserted-by":"crossref","first-page":"52629","DOI":"10.1074\/jbc.M308175200","volume":"278","author":"MK Al-Shawi","year":"2003","unstructured":"Al-Shawi MK, Polar MK, Omote H, Figler RA (2003) Transition states analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein. J Biol Chem 278:52629\u201352640","journal-title":"J Biol Chem"},{"key":"609_CR2","doi-asserted-by":"crossref","first-page":"21160","DOI":"10.1074\/jbc.272.34.21160","volume":"272","author":"SV Ambadkar","year":"1997","unstructured":"Ambadkar SV, Cardarelli CO, Pashinsky I, Stein W (1997) Relation between the turnover for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein. J Biol Chem 272:21160\u201321166","journal-title":"J Biol Chem"},{"key":"609_CR3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jps.2600790604","volume":"9","author":"P Artursson","year":"1990","unstructured":"Artursson P (1990) Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci 9:476\u2013482","journal-title":"J Pharm Sci"},{"key":"609_CR4","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1074\/jbc.271.6.3163","volume":"271","author":"JM Borgnia","year":"1996","unstructured":"Borgnia JM, Eytant DG, Assaraf GY (1996) Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. J Biol Chem 271:3163\u20133171","journal-title":"J Biol Chem"},{"key":"609_CR5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"609_CR6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nbd.2006.06.014","volume":"24","author":"C Brandt","year":"2006","unstructured":"Brandt C, Kerstin B, Alexandra MG, L\u00f6scher W (2006) The multidrug transporter hypothesis of drug resistance in epilepsy: proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiol Dis 24:202\u2013211","journal-title":"Neurobiol Dis"},{"key":"609_CR7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neuroscience.2010.06.073","volume":"170","author":"RS Camenzind","year":"2010","unstructured":"Camenzind RS, Chip S, Gutmann H, Kapfhammer JP, Nitsch C, Bendfeldt K (2010) Preservation of transendothelial glucose transporter 1 and P-glycoprotein transporter in a cortical slice culture model of blood\u2013brain barrier. Neuroscience 170:361\u2013371","journal-title":"Neuroscience"},{"key":"609_CR8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1124\/jpet.105.085514","volume":"312","author":"R Clinckers","year":"2005","unstructured":"Clinckers R, Smolders I, Meurs A, Ebinger G, Michotte Y (2005) Quantitative in vivo microdialysis study on the influence of multidrug transporters on the blood\u2013brain barrier passage of oxcarbazepine: concomitant use of hippocampal monoamines as pharmacodynamic markers for the anticonvulsant activity. J Pharmacol Exp Ther 312:725\u2013731","journal-title":"J Pharmacol Exp Ther"},{"key":"609_CR9","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1046\/j.1528-1157.2001.12301.x","volume":"42","author":"SM Dombrowski","year":"2001","unstructured":"Dombrowski SM, Desai SY, Marroni M, Cucullo L, Goodrich K, Bingaman W, Mayberg MR, Bengez L, Janigro D (2001) Overexpression of multidrug drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 42:1501\u20131506","journal-title":"Epilepsia"},{"key":"609_CR10","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/j.1476-5381.2009.00634.x","volume":"159","author":"XY Jing","year":"2010","unstructured":"Jing XY, Liu X, Wen T, Xie SS, Yao D, Liu XD, Wang GJ, Xie L (2010) Combined effects of epileptic seizure and phenobarbital induced overexpression of P-glycoprotein in brain of chemically kindled rats. Br J Pharmacol 159:1511\u20135122","journal-title":"Br J Pharmacol"},{"key":"609_CR11","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.1021\/bi034149+","volume":"42","author":"J Karwatsky","year":"2003","unstructured":"Karwatsky J, Lincoln MC, Georges E (2003) A mechanism for P-glycoprotein-mediated apoptosis as revealed by verapamil hypersensitivity. Biochemistry 42:12163\u201312173","journal-title":"Biochemistry"},{"key":"609_CR12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.phrs.2010.07.001","volume":"62","author":"BP Kota","year":"2010","unstructured":"Kota BP, Tran VH, Allen J, Bebawy M, Roufogalis BD (2010) Characterization of PXR mediated P-glycoprotein regulation in intestinal LS174T cells. Pharmacol Res 62:426\u2013431","journal-title":"Pharmacol Res"},{"key":"609_CR13","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00259-009-1332-5","volume":"37","author":"C Kunter","year":"2010","unstructured":"Kunter C, Bankstahl JP, Bankstahl M, Stanek J, Wanek T, Stundner G, Karch R, Brauner R, Meier M, Ding X, M\u00fcller M, L\u00f6scher W (2010) Dose\u2013response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood\u2013brain barrier using (R)-[11C] verapamil PET. Eur J Nucl Med Mol Imaging 37:942\u2013953","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"609_CR14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.yebeh.2004.08.002","volume":"5","author":"P Kwan","year":"2004","unstructured":"Kwan P, Brodie MJ (2004) Phenobarbital: a drug for the 21st century? Epilepsy Behav 5:802\u2013803","journal-title":"Epilepsy Behav"},{"key":"609_CR15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejphar.2007.01.062","volume":"561","author":"HY Liu","year":"2007","unstructured":"Liu HY, Zhang DM, Xu X, Liu XD, Wang GJ, Xie L, Pang XY, Liu L (2007a) Attenuated function and expression of P-glycoprotein at blood\u2013brain barrier and increased brain distribution of phenobarbital in streptozotocin-induced diabetic mice. Eur J Pharmacol 561:226\u2013232","journal-title":"Eur J Pharmacol"},{"key":"609_CR16","first-page":"111","volume":"22","author":"XD Liu","year":"2001","unstructured":"Liu XD, Liu GQ (2001) P-glycoprotein regulated transport of glutamate at blood barrier. Acta Pharmacol Sin 22:111\u2013116","journal-title":"Acta Pharmacol Sin"},{"key":"609_CR17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.neuropharm.2007.07.012","volume":"53","author":"XD Liu","year":"2007","unstructured":"Liu XD, Yang ZH, Yang JS, Yang HW (2007b) Increased P-glycoprotein expression and decreased phenobarbital distribution in the brain of pentylenetetrazole-kindled rats. Neuropharmacology 53:657\u2013663","journal-title":"Neuropharmacology"},{"key":"609_CR18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neulet.2007.12.017","volume":"432","author":"XD Liu","year":"2008","unstructured":"Liu XD, Yang ZH, Yang HW (2008) Repetitive\/temporal hypoxia increased P-glycoprotein expression in cultured rat brain microvascular endothelial cells in vitro. Neurosci Lett 432:184\u2013187","journal-title":"Neurosci Lett"},{"key":"609_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/jpet.301.1.7","volume":"301","author":"W L\u00f6scher","year":"2002","unstructured":"L\u00f6scher W, Potschka H (2002) Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 301:7\u201314","journal-title":"J Pharmacol Exp Ther"},{"key":"609_CR20","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1471-4159.2010.07054.x","volume":"115","author":"VK Manda","year":"2010","unstructured":"Manda VK, Mittapalli RK, Bohn KA, Adkins CE, Lockman PR (2010) Nicotine and cotinine increases the brain penetration of saquinavir in rat. J Neurochem 115:1495\u20131507","journal-title":"J Neurochem"},{"key":"609_CR21","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0022-3565(25)24383-X","volume":"238","author":"RJ Marley","year":"1986","unstructured":"Marley RJ, Miner LL, Wehner JM, Collins AC (1986) Differential effects of central nervous system depressants in long-sleep and short-sleep mice. J Pharmacol Exp Ther 238:1028\u20131033","journal-title":"J Pharmacol Exp Ther"},{"key":"609_CR22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.bjp.0701429","volume":"122","author":"C Martin","year":"1997","unstructured":"Martin C, Berridge G, Higgins FC, Callaghan R (1997) The multi-drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P-glycoprotein by an allosteric interaction. Br J Pharmacol 122:765\u2013771","journal-title":"Br J Pharmacol"},{"key":"609_CR23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(00)00180-1","volume":"395","author":"Y Mitsunaga","year":"2000","unstructured":"Mitsunaga Y, Takanaga H, Matsuo H, Naito M, Tsuruo T, Ohtani H, Sawada Y (2000) Effect of bioflavonoids on vincristine transport across blood\u2013brain barrier. Eur J Pharmacol 395:193\u2013201","journal-title":"Eur J Pharmacol"},{"key":"609_CR24","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1248\/bpb.31.2302","volume":"31","author":"A Nishimura","year":"2008","unstructured":"Nishimura A, Honda N, Sugioka N, Takada K, Shibata N (2008) Evaluation of carbamazepine pharmacokinetic profiles in mice with kainic acid-induced acute seizures. Biol Pharm Bull 31:2302\u20132308","journal-title":"Biol Pharm Bull"},{"key":"609_CR25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1042\/bj3170515","volume":"317","author":"S Orlowski","year":"1996","unstructured":"Orlowski S, Mir LM, Belehradek J, Garrigos M (1996) Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. J Biochem 317:515\u2013522","journal-title":"J Biochem"},{"key":"609_CR26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/mol.108.050492","volume":"75","author":"MM Pires","year":"2009","unstructured":"Pires MM, Emmert D, Hrycyna CA, Chmielewski J (2009) Inhibition of P-glycoprotein-mediated paclitaxel resistance by reversibly linked quinine homodimers. Mol Pharmacol 75:92\u2013100","journal-title":"Mol Pharmacol"},{"key":"609_CR27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(02)00423-8","volume":"327","author":"H Potschka","year":"2002","unstructured":"Potschka H, Fedrowitz M, L\u00f6scher W (2002) P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine and felbamate at blood\u2013brain barrier: evidence from microdialysis experiments in rats. Neurosci Lett 327:173\u2013176","journal-title":"Neurosci Lett"},{"key":"609_CR28","first-page":"42","volume":"21","author":"ZY Qian","year":"1999","unstructured":"Qian ZY, Huang Q, Zhou LY, Sun ZF (1999) Isolation and long-term cultivation of rat brain microvascular endothelial cells. Chin J Cell Biol 21:42\u201345","journal-title":"Chin J Cell Biol"},{"key":"609_CR29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/brain\/awh682","volume":"129","author":"S Remy","year":"2006","unstructured":"Remy S, Beck H (2006) Molecular and cellular mechanism of pharmacoresistance in epilepsy. Brain 129:18\u201335","journal-title":"Brain"},{"key":"609_CR30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","volume":"36","author":"AH Schinkel","year":"1999","unstructured":"Schinkel AH (1999) P-Glycoprotein, a gatekeeper in the blood\u2013brain barrier. Adv Drug Deliv Rev 36:179\u2013194","journal-title":"Adv Drug Deliv Rev"},{"key":"609_CR31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1528-1157.2002.33101.x","volume":"43","author":"U Seegers","year":"2002","unstructured":"Seegers U, Potschka H, L\u00f6scher W (2002) Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats. Epilepsia 43:675\u2013684","journal-title":"Epilepsia"},{"key":"609_CR32","doi-asserted-by":"crossref","first-page":"10334","DOI":"10.1074\/jbc.270.17.10334","volume":"270","author":"FJ Sharom","year":"1995","unstructured":"Sharom FJ, DiDiodato G, Yu X, Ashbourne KJ (1995) Interaction of the P-glycoprotein multidrug transporter with peptides and ionophores. J Biol Chem 270:10334\u201310341","journal-title":"J Biol Chem"},{"key":"609_CR33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/brain\/awf002","volume":"125","author":"SM Sisodiya","year":"2002","unstructured":"Sisodiya SM, Lin WR, Harding BN, Squier MV, Thom M (2002) Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125:22\u201331","journal-title":"Brain"},{"key":"609_CR34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1745-7254.2006.00246.x","volume":"27","author":"JJ Sun","year":"2006","unstructured":"Sun JJ, Xie L, Liu XD (2006) Transport of cabamazepine and drug interaction at blood brain barrier. Acta Pharmacol Sin 27:249\u2013253","journal-title":"Acta Pharmacol Sin"},{"key":"609_CR35","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1124\/dmd.105.005421","volume":"33","author":"ME Taub","year":"2005","unstructured":"Taub ME, Podila L, Ely D, Almeida L (2005) Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity. Drug Metab Dispos 33:1679\u20131687","journal-title":"Drug Metab Dispos"},{"key":"609_CR36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.intimp.2008.11.007","volume":"9","author":"S Tanaka","year":"2009","unstructured":"Tanaka S, Masuda M, Nakajima K, Ido N, Ohtsuka T, Nishida M (2009) P-glycoprotein function in peripheral T lymphocyte subsets of myasthenia gravis patients: clinical implications and influence of glucocorticoid administration. Int Immunopharmacol 9:284\u2013290","journal-title":"Int Immunopharmacol"},{"key":"609_CR37","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1528-1167.2006.00496.x","volume":"47","author":"EA Vliet Van","year":"2006","unstructured":"Van Vliet EA, Van Schaik R, Edelbroek PM, Redeker S, Aronica E, Wadman WJ, Marchi N, Vezzani A, Dorter JA (2006) Inhibition of the multidrug transporter p-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia 47:672\u2013680","journal-title":"Epilepsia"},{"key":"609_CR38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejps.2004.07.006","volume":"23","author":"KS Vellonen","year":"2006","unstructured":"Vellonen KS, Honkakoski P, Urtti A (2006) Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity. Eur J Pharm Sci 23:181\u2013188","journal-title":"Eur J Pharm Sci"},{"key":"609_CR39","first-page":"86","volume":"11","author":"M Vesna","year":"2010","unstructured":"Vesna M, Zeljko K, Lara M, Vesna EH (2010) Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays. Eur J Pharm Sci 11:86\u201395","journal-title":"Eur J Pharm Sci"},{"key":"609_CR40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.bjp.0701377","volume":"122","author":"T Watanabe","year":"1997","unstructured":"Watanabe T, Kokubu N, Charnick SB, Naito M, Tsuruo T, Cohen D (1997) Interaction of cyclosporine derivatives with the ATPase activity of human P-glycoprotein. Br J Pharmacol 122:241\u2013248","journal-title":"Br J Pharmacol"},{"key":"609_CR41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.eplepsyres.2007.10.006","volume":"78","author":"ZH Yang","year":"2008","unstructured":"Yang ZH, Liu XD (2008) P-glycoprotein-mediated efflux of phenobarbital at the blood\u2013brain barrier evidence from transport experiments in vitro. Epilepsy Res 78:40\u201349","journal-title":"Epilepsy Res"},{"key":"609_CR42","first-page":"903","volume":"24","author":"L Zhang","year":"2003","unstructured":"Zhang L, Liu XD, Xie L, Wang GJ (2003) P-glycoprotein restricted transport of nimodipine across blood\u2013brain barrier. Acta Pharmacol Sin 24:903\u2013906","journal-title":"Acta Pharmacol Sin"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-011-0609-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-011-0609-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-011-0609-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T19:29:53Z","timestamp":1740943793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-011-0609-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,19]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["609"],"URL":"https:\/\/doi.org\/10.1007\/s00210-011-0609-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,19]]}}}